Molina Healthcare, Inc. (MOH) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2025. Molina Healthcare, Inc. provides managed healthcare services primarily under Medicaid, Medicare, and state insurance Marketplaces. As of the reporting date, the company served approximately 5.6 million members across 21 states. The company operates four reportable segments: Medicaid, Medicare, Marketplace, and Other.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Total Revenue | $11,477 million | $10,340 million | $34,051 million | $30,151 million |
| Premium Revenue | $10,841 million | $9,694 million | $32,337 million | $28,644 million |
| Net Income | $79 million | $326 million | $632 million | $928 million |
| Diluted EPS | $1.51 | $5.65 | $11.79 | $15.97 |
| Operating Income | $137 million | $467 million | $943 million | $1,327 million |
| Medical Care Ratio (MCR) | 92.6% | 89.2% | 90.8% | 88.8% |
| Long-Term Debt | $3,664 million | $2,923 million (Dec 2024) | N/A | N/A |
| Cash & Investments | $8,447 million | $8,987 million (Dec 2024) | N/A | N/A |
Note: Cash and investments calculated as Cash ($4,221M) + Investments ($4,226M) + Restricted Investments ($300M).
Material Changes vs. Prior Period
- Profitability Decline: Net income dropped significantly by 76% in Q3 2025 compared to Q3 2024 ($79M vs. $326M). This was driven by a sharp increase in the Medical Care Ratio (MCR) and higher interest expenses.
- Medical Cost Pressure: The consolidated MCR increased to 92.6% in Q3 2025 from 89.2% in the prior year. This trend was observed across all segments, with the Marketplace segment seeing the most dramatic increase (95.6% vs. 73.0% YoY) due to higher utilization and risk adjustment mismatches.
- Revenue Growth: Premium revenue grew 12% in Q3 2025, driven by the ConnectiCare acquisition, rate increases, and membership growth, partially offset by Medicaid contract terminations (Virginia).
- Debt Expansion: Long-term debt increased by approximately $741 million year-over-year due to new term loans ($740M outstanding) and the issuance of senior notes to fund acquisitions and operations.
- Cash Flow: Operating cash flow turned negative, using $237 million in the first nine months of 2025, compared to providing $868 million in the same period in 2024. This shift is attributed to timing differences in government settlements and lower net income.
Outlook, Risks, and Management Commentary
- Regulatory Impact (OBBBA): The "One Big Beautiful Bill Act" signed in July 2025 introduces work requirements and cost-sharing for Medicaid expansion, expected to reduce enrollment by 15-20% (approx. 1.3 million members) over 2027-2029. It also limits provider taxes and Marketplace subsidies.
- Acquisition Integration: The company closed the $350 million acquisition of ConnectiCare in February 2025, adding ~140,000 members. While driving revenue, the acquisition contributed to initial MCR pressures in the Marketplace and Medicare segments.
- Contract Wins & Losses: Molina secured new contracts in Mississippi, Nevada, Illinois, Florida, and Wisconsin. However, the Virginia Medicaid contract terminated on June 30, 2025, following a lost bid protest.
- Capital Allocation: The company repurchased $1 billion of common stock in the first nine months of 2025. A new $1 billion repurchase program was authorized in April 2025, with $500 million remaining as of October 2025.
- Risks: Key risks include the implementation of the OBBBA, state budget pressures leading to rate reductions, unfavorable medical cost trends, and the potential for retroactive premium adjustments.
Investor Verification Checklist
- MCR Sustainability: Verify if the 92.6% MCR is a temporary anomaly or a structural shift, particularly in the Marketplace segment where it jumped to 95.6%.
- Virginia Termination Impact: Assess the long-term revenue and margin impact of the Virginia contract loss versus new wins in Mississippi, Nevada, and Florida.
- Debt Servicing: Review the impact of increased interest expense ($49M in Q3 vs. $29M in Q3 2024) on future earnings, especially with $3.66B in long-term debt.
- Regulatory Timeline: Monitor the implementation schedule of the OBBBA provisions (2027-2029) and their specific impact on the 1.3 million expansion members.
- Cash Flow Reversal: Investigate the drivers behind the negative operating cash flow ($237M used) and whether this is a timing issue or a liquidity concern.